BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3933000)

  • 1. [Effect of x-ray irradiation on the biological properties of Mycobacterium tuberculosis].
    Golyshevskaia VI; Bibergal' EA
    Probl Tuberk; 1985; (8):53-6. PubMed ID: 3933000
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the biological properties of Mycobacterium tuberculosis as affected by x-ray radiation].
    Golyshevskaia VI; Bibergal' EA
    Probl Tuberk; 1986; (9):47-50. PubMed ID: 3097634
    [No Abstract]   [Full Text] [Related]  

  • 3. [Improved methods of isolating altered forms of Mycobacterium tuberculosis in patients with stable destructive changes in lung tissue].
    Golyshevskaia VI; Akhunov ShB; Bibergal' EA
    Probl Tuberk; 1987; (10):61-5. PubMed ID: 3122201
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical course and chemotherapy of hyperchronic destructive pulmonary tuberculosis].
    Mamolat AS; Bialik IB; Khutorskaia VD
    Probl Tuberk; 1985; (10):24-8. PubMed ID: 3934660
    [No Abstract]   [Full Text] [Related]  

  • 5. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 6. [Formation of a filterable form of the causative agent of tuberculosis in the chemotherapy process (an experimental study)].
    Khomenko AK; Golyshevskaia VI; Korolev MB; Drozdov SG
    Probl Tuberk; 1982 Mar; (3):50-4. PubMed ID: 6806805
    [No Abstract]   [Full Text] [Related]  

  • 7. [The nature of bacterial shedding and its effect on treatment outcome in newly detected patients with destructive pulmonary tuberculosis].
    Omarov TO; Krivtsova AE; Kumisbaeva BT
    Probl Tuberk; 1988; (8):19-20. PubMed ID: 2974156
    [No Abstract]   [Full Text] [Related]  

  • 8. Variability of mycobacterial population in the process of the experimental chemotherapy of tuberculosis.
    Golyshevskaya VI
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1986; 35(3):263-6. PubMed ID: 3027864
    [No Abstract]   [Full Text] [Related]  

  • 9. [Methods in the modern chemotherapy of tuberculosis (a lecture)].
    Khomenko AG
    Probl Tuberk; 1988; (8):53-7. PubMed ID: 3143997
    [No Abstract]   [Full Text] [Related]  

  • 10. [Place of bacteriological examination in the treatment of tuberculosis].
    Gyselen A
    Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of biological assay in the detection of "latent" bacteria release during chemotherapy].
    Posperov VV; Pashkov IuN; Lobchenko AI
    Probl Tuberk; 1982 Aug; (8):62-6. PubMed ID: 6815644
    [No Abstract]   [Full Text] [Related]  

  • 12. [An evaluation of the results of the use of a short-duration chemotherapy regimen (3+3) in cases with tuberculosis of the respiratory tract in 1986].
    Didilescu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989; 38(2):173-5. PubMed ID: 2555903
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dynamics of bacterial populations in experimental destructive pulmonary tuberculosis under treatment].
    Golişevskaia V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(2):111-4. PubMed ID: 6264575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of different chemotherapy regimens with pulmonary tuberculosis patients based on the data from a comprehensive bacteriological study].
    Muratov VV; Pashkov IuN; Chukanov VI
    Probl Tuberk; 1983 May; (5):34-8. PubMed ID: 6408636
    [No Abstract]   [Full Text] [Related]  

  • 15. [Morphologic and biochemical changes in Mycobacterium tuberculosis during chemotherapy].
    Khomenko AG; Fadeeva NI; Golyshevskaia VI
    Probl Tuberk; 1983 Jul; (7):48-54. PubMed ID: 6415652
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens].
    Muratov VV; Pashkov IuN; Pospelov VV
    Probl Tuberk; 1981 Dec; (12):30-4. PubMed ID: 6801646
    [No Abstract]   [Full Text] [Related]  

  • 17. [The optimization of the corticosteroid therapy of patients with destructive pulmonary tuberculosis].
    Iareshko AG
    Vrach Delo; 1989 Nov; (11):39-40. PubMed ID: 2514485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systematic research on asymptomatic bacilluria in 120 non selected cases of pulmonary tuberculosis].
    Favez G; Nicca B; Pressia O
    Schweiz Med Wochenschr; 1972 Jun; 102(25):877-80. PubMed ID: 4624459
    [No Abstract]   [Full Text] [Related]  

  • 19. [Characteristics of infiltrative pulmonary tuberculosis located in the inferior lobe].
    Andriushina KM; Borodina NV; Savenkova DI; Oliferovskaia RP
    Klin Med (Mosk); 1985 Dec; 63(12):48-50. PubMed ID: 3937943
    [No Abstract]   [Full Text] [Related]  

  • 20. [The nature of bacterial secretions in patients with focal pulmonary tuberculosis].
    Il'ina TIa
    Probl Tuberk; 1974; (10):6-10. PubMed ID: 4213567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.